# Jazz Pharmaceuticals plc

> Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero.

## Record

| Field | Value |
| --- | --- |
| Representation | alpha-profile-markdown-v4 |
| Protocol | Alpha Governance Facts Protocol 0.1 |
| Schema | alpha.governance.entity.public.v1 |
| Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce |
| Governance record representation | alpha-governance-record-v2 |
| Canonical entity | alpha:company:949442cd-411d-47fd-9b77-1797c485ab61 |
| Entity type | Company |
| Canonical URL | https://registry.alpha.ac/companies/jazz-pharmaceuticals-plc |
| Publication | PUBLISHED |
| Verification | source_reported |
| Verification schema | alpha-verification-states-v1 |
| Ownership | unclaimed |
| Published claims | 29 |
| Claims under review | 2 |
| Evidence records | 14 |
| Conflicts | 0 |
| Conflicts in internal review | 0 |
| Observed | 2026-10-16T04:45:29.143592+00:00 |
| Last reviewed | 2026-10-16T04:45:29.143592+00:00 |

## Identity

- Legal name: Jazz Pharmaceuticals plc
- Display name: Jazz Pharmaceuticals plc

## Alpha Governance Record

| Field | Value |
| --- | --- |
| Governance Record schema | alpha-governance-record-v2 |
| Ontology | alpha-governance-ontology-v1 |
| Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce |
| As of | 2026-10-16T09:56:14.582154+00:00 |
| Completeness | 0.364 |
| Record Quality | 0.798 |
| Directors | 12 |
| Committees | 0 |
| Governance events | 13 |
| Entity class | public_company |

## Section coverage

| Section | State |
| --- | --- |
| identity | PUBLISHED |
| corporate_structure | NOT_REVIEWED |
| board | PUBLISHED |
| committees | NOT_REVIEWED |
| leadership | PUBLISHED |
| ownership | NOT_REVIEWED |
| financials | NOT_REVIEWED |
| capital_structure | PUBLISHED |
| compensation | NOT_REVIEWED |
| governance | NOT_REVIEWED |
| shareholder_governance | NOT_REVIEWED |
| audit | NOT_REVIEWED |
| legal | NOT_REVIEWED |
| risk | NOT_REVIEWED |
| cyber | NOT_REVIEWED |
| ai_governance | NOT_REVIEWED |
| agent_governance | RESTRICTED |
| markets_external | NOT_REVIEWED |
| events | PUBLISHED |
| relationships | PUBLISHED |
| assessments | PUBLISHED |
| evidence | PUBLISHED |

## Board

- Anne O'Riordan: Director. Status: current. Independent: true. Since: 2019-01-01. claim_id=alpha:claim:company:949442cd-411d-47fd-9b77-1797c485ab61:leadership_role:7
- Bruce C. Cozadd: Director. Status: current. Independent: false. Since: 2003-01-01. claim_id=alpha:claim:company:949442cd-411d-47fd-9b77-1797c485ab61:leadership_role:8
- Heather Ann McSharry: Director. Status: current. Independent: true. Since: 2013-01-01. claim_id=alpha:claim:company:949442cd-411d-47fd-9b77-1797c485ab61:leadership_role:9
- Jennifer E. Cook: Director. Status: current. Independent: true. Since: 2020-01-01. claim_id=alpha:claim:company:949442cd-411d-47fd-9b77-1797c485ab61:leadership_role:10
- Kenneth W. O'Keefe: Director. Status: current. Independent: true. Since: 2004-01-01. claim_id=alpha:claim:company:949442cd-411d-47fd-9b77-1797c485ab61:leadership_role:11
- Laura J. Hamill: Director. Status: current. Independent: true. Since: 2024-01-01. claim_id=alpha:claim:company:949442cd-411d-47fd-9b77-1797c485ab61:leadership_role:12
- Mark D. Smith: Director. Status: current. Independent: true. Since: 2020-01-01. claim_id=alpha:claim:company:949442cd-411d-47fd-9b77-1797c485ab61:leadership_role:13
- Norbert G. Riedel: Director. Status: current. Independent: true. Since: 2013-01-01. claim_id=alpha:claim:company:949442cd-411d-47fd-9b77-1797c485ab61:leadership_role:14
- Patrick G. Enright: Director. Status: current. Independent: true. Since: 2009-01-01. claim_id=alpha:claim:company:949442cd-411d-47fd-9b77-1797c485ab61:leadership_role:15
- Patrick Kennedy: Director. Status: current. Independent: true. Since: 2024-01-01. claim_id=alpha:claim:company:949442cd-411d-47fd-9b77-1797c485ab61:leadership_role:16
- Rick E Winningham: Director. Status: current. Independent: true. Since: 2010-01-01. claim_id=alpha:claim:company:949442cd-411d-47fd-9b77-1797c485ab61:leadership_role:17
- Seamus Mulligan: Director. Status: current. Independent: true. Since: 2012-01-01. claim_id=alpha:claim:company:949442cd-411d-47fd-9b77-1797c485ab61:leadership_role:18

## Executive leadership

- Bruce C. Cozadd: Chief Executive Officer [CEO]. Status: current. claim_id=alpha:claim:company:949442cd-411d-47fd-9b77-1797c485ab61:leadership_role:19
- George Christopher Eliades: Senior Vice President & Chief Transformation Officer. Status: unknown. claim_id=alpha:claim:company:949442cd-411d-47fd-9b77-1797c485ab61:leadership_role:20
- Heidi Manna: Executive Vice President & Chief People Officer [CHRO]. Status: unknown. claim_id=alpha:claim:company:949442cd-411d-47fd-9b77-1797c485ab61:leadership_role:21
- Jed Black: Senior Vice President of Sleep & CNS Medicine. Status: unknown. claim_id=alpha:claim:company:949442cd-411d-47fd-9b77-1797c485ab61:leadership_role:22
- John Miller: Senior Vice President of Corporate Strategy. Status: unknown. claim_id=alpha:claim:company:949442cd-411d-47fd-9b77-1797c485ab61:leadership_role:23
- Mary Elizabeth Henderson: Senior Vice President of Technical Operations. Status: unknown. claim_id=alpha:claim:company:949442cd-411d-47fd-9b77-1797c485ab61:leadership_role:24
- Neena Patil: Executive Vice President & Chief Legal Officer [GC]. Status: unknown. claim_id=alpha:claim:company:949442cd-411d-47fd-9b77-1797c485ab61:leadership_role:25
- Patricia Carr: Senior Vice President & Chief Accounting Officer [CAO]. Status: unknown. claim_id=alpha:claim:company:949442cd-411d-47fd-9b77-1797c485ab61:leadership_role:26
- Philip L. Johnson: Executive Vice President & Chief Financial Officer [CFO]. Status: unknown. claim_id=alpha:claim:company:949442cd-411d-47fd-9b77-1797c485ab61:leadership_role:27
- Renee D. Gala: President, Chief Executive Officer & Director [CEO]. Status: unknown. claim_id=alpha:claim:company:949442cd-411d-47fd-9b77-1797c485ab61:leadership_role:28
- Robert Iannone: Executive Vice President, Chief Medical Officer and Global Head of Research & Development. Status: unknown. claim_id=alpha:claim:company:949442cd-411d-47fd-9b77-1797c485ab61:leadership_role:29
- Samantha Pearce: Executive Vice President & Chief Commercial Officer. Status: unknown. claim_id=alpha:claim:company:949442cd-411d-47fd-9b77-1797c485ab61:leadership_role:30

## Governance events

- CEO_CHANGED: Bruce C. Cozadd executive of Jazz Pharmaceuticals plc, effective 2025-06-06. Effective: 2025-06-06. Detected: 2026-10-16T04:45:29.143592+00:00. event_id=alpha:event:transition:w2zzkn1p9dw4z
- DIRECTOR_APPOINTED: Laura J. Hamill seat on Jazz Pharmaceuticals plc, effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-16T04:45:29.143592+00:00. event_id=alpha:event:transition:1ltdh3jdpdjjl
- DIRECTOR_APPOINTED: Patrick Kennedy seat on Jazz Pharmaceuticals plc, effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-16T04:45:29.143592+00:00. event_id=alpha:event:transition:1f7m7pp1vj4k4h
- DIRECTOR_APPOINTED: Jennifer E. Cook seat on Jazz Pharmaceuticals plc, effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-16T04:45:29.143592+00:00. event_id=alpha:event:transition:6a6dxp11wxynj
- DIRECTOR_APPOINTED: Mark D. Smith seat on Jazz Pharmaceuticals plc, effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-16T04:45:29.143592+00:00. event_id=alpha:event:transition:1awfgggubjlds
- DIRECTOR_APPOINTED: Anne O'Riordan seat on Jazz Pharmaceuticals plc, effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-16T04:45:29.143592+00:00. event_id=alpha:event:transition:3bgdtj1ogpbfz
- DIRECTOR_APPOINTED: Heather Ann McSharry seat on Jazz Pharmaceuticals plc, effective 2013-01-01. Effective: 2013-01-01. Detected: 2026-10-16T04:45:29.143592+00:00. event_id=alpha:event:transition:1k8vfefgqi9lf
- DIRECTOR_APPOINTED: Norbert G. Riedel seat on Jazz Pharmaceuticals plc, effective 2013-01-01. Effective: 2013-01-01. Detected: 2026-10-16T04:45:29.143592+00:00. event_id=alpha:event:transition:iw2ieffh9myn
- DIRECTOR_APPOINTED: Seamus Mulligan seat on Jazz Pharmaceuticals plc, effective 2012-01-01. Effective: 2012-01-01. Detected: 2026-10-16T04:45:29.143592+00:00. event_id=alpha:event:transition:1kw2e5cy0tgna
- DIRECTOR_APPOINTED: Rick E Winningham seat on Jazz Pharmaceuticals plc, effective 2010-01-01. Effective: 2010-01-01. Detected: 2026-10-16T04:45:29.143592+00:00. event_id=alpha:event:transition:1d17z631yljyv3
- DIRECTOR_APPOINTED: Patrick G. Enright seat on Jazz Pharmaceuticals plc, effective 2009-01-01. Effective: 2009-01-01. Detected: 2026-10-16T04:45:29.143592+00:00. event_id=alpha:event:transition:ph3gk3ancdep
- DIRECTOR_APPOINTED: Kenneth W. O'Keefe seat on Jazz Pharmaceuticals plc, effective 2004-01-01. Effective: 2004-01-01. Detected: 2026-10-16T04:45:29.143592+00:00. event_id=alpha:event:transition:13cbz9ss6whys
- DIRECTOR_APPOINTED: Bruce C. Cozadd seat on Jazz Pharmaceuticals plc, effective 2003-01-01. Effective: 2003-01-01. Detected: 2026-10-16T04:45:29.143592+00:00. event_id=alpha:event:transition:ve3xf71nf73l7

## Scoped resources

- `alpha://company/jazz-pharmaceuticals-plc` (contract): https://registry.alpha.ac/api/public/companies/jazz-pharmaceuticals-plc?format=record
- `alpha://company/jazz-pharmaceuticals-plc/identity` (contract): https://registry.alpha.ac/api/public/companies/jazz-pharmaceuticals-plc?format=record&section=identity
- `alpha://company/jazz-pharmaceuticals-plc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/jazz-pharmaceuticals-plc?format=record&section=corporate-structure
- `alpha://company/jazz-pharmaceuticals-plc/board` (contract): https://registry.alpha.ac/api/public/companies/jazz-pharmaceuticals-plc?format=record&section=board
- `alpha://company/jazz-pharmaceuticals-plc/committees` (contract): https://registry.alpha.ac/api/public/companies/jazz-pharmaceuticals-plc?format=record&section=committees
- `alpha://company/jazz-pharmaceuticals-plc/leadership` (contract): https://registry.alpha.ac/api/public/companies/jazz-pharmaceuticals-plc?format=record&section=leadership
- `alpha://company/jazz-pharmaceuticals-plc/ownership` (contract): https://registry.alpha.ac/api/public/companies/jazz-pharmaceuticals-plc?format=record&section=ownership
- `alpha://company/jazz-pharmaceuticals-plc/financials` (contract): https://registry.alpha.ac/api/public/companies/jazz-pharmaceuticals-plc?format=record&section=financials
- `alpha://company/jazz-pharmaceuticals-plc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/jazz-pharmaceuticals-plc?format=record&section=capital-structure
- `alpha://company/jazz-pharmaceuticals-plc/compensation` (contract): https://registry.alpha.ac/api/public/companies/jazz-pharmaceuticals-plc?format=record&section=compensation
- `alpha://company/jazz-pharmaceuticals-plc/governance` (contract): https://registry.alpha.ac/api/public/companies/jazz-pharmaceuticals-plc?format=record&section=governance
- `alpha://company/jazz-pharmaceuticals-plc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/jazz-pharmaceuticals-plc?format=record&section=shareholder-governance
- `alpha://company/jazz-pharmaceuticals-plc/audit` (contract): https://registry.alpha.ac/api/public/companies/jazz-pharmaceuticals-plc?format=record&section=audit
- `alpha://company/jazz-pharmaceuticals-plc/legal` (contract): https://registry.alpha.ac/api/public/companies/jazz-pharmaceuticals-plc?format=record&section=legal
- `alpha://company/jazz-pharmaceuticals-plc/risk` (contract): https://registry.alpha.ac/api/public/companies/jazz-pharmaceuticals-plc?format=record&section=risk
- `alpha://company/jazz-pharmaceuticals-plc/cyber` (contract): https://registry.alpha.ac/api/public/companies/jazz-pharmaceuticals-plc?format=record&section=cyber
- `alpha://company/jazz-pharmaceuticals-plc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/jazz-pharmaceuticals-plc?format=record&section=ai-governance
- `alpha://company/jazz-pharmaceuticals-plc/agents` (contract): https://registry.alpha.ac/api/public/companies/jazz-pharmaceuticals-plc?format=record&section=agents
- `alpha://company/jazz-pharmaceuticals-plc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/jazz-pharmaceuticals-plc?format=record&section=ecosystem
- `alpha://company/jazz-pharmaceuticals-plc/events` (contract): https://registry.alpha.ac/api/public/companies/jazz-pharmaceuticals-plc?format=record&section=events
- `alpha://company/jazz-pharmaceuticals-plc/relationships` (contract): https://registry.alpha.ac/api/public/companies/jazz-pharmaceuticals-plc?format=record&section=relationships
- `alpha://company/jazz-pharmaceuticals-plc/assessments` (contract): https://registry.alpha.ac/api/public/companies/jazz-pharmaceuticals-plc?format=record&section=assessments
- `alpha://company/jazz-pharmaceuticals-plc/evidence` (contract): https://registry.alpha.ac/api/public/companies/jazz-pharmaceuticals-plc?format=record&section=evidence

## Role modules

- NOT_ASSERTED

## Attention

- NO_RECORDS_FOUND

## Committee data

- NO_RECORDS_FOUND

## Leadership

- Anne O'Riordan: Director. Claim: alpha:claim:company:949442cd-411d-47fd-9b77-1797c485ab61:leadership_role:7. Valid from: 2019-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5163f9ed312a579335fb257ccc13cd0586e4a85f31dac06879e3c5d4111a1fba.
- Bruce C. Cozadd: Director. Claim: alpha:claim:company:949442cd-411d-47fd-9b77-1797c485ab61:leadership_role:8. Valid from: 2003-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5163f9ed312a579335fb257ccc13cd0586e4a85f31dac06879e3c5d4111a1fba.
- Heather Ann McSharry: Director. Claim: alpha:claim:company:949442cd-411d-47fd-9b77-1797c485ab61:leadership_role:9. Valid from: 2013-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5163f9ed312a579335fb257ccc13cd0586e4a85f31dac06879e3c5d4111a1fba.
- Jennifer E. Cook: Director. Claim: alpha:claim:company:949442cd-411d-47fd-9b77-1797c485ab61:leadership_role:10. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5163f9ed312a579335fb257ccc13cd0586e4a85f31dac06879e3c5d4111a1fba.
- Kenneth W. O'Keefe: Director. Claim: alpha:claim:company:949442cd-411d-47fd-9b77-1797c485ab61:leadership_role:11. Valid from: 2004-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5163f9ed312a579335fb257ccc13cd0586e4a85f31dac06879e3c5d4111a1fba.
- Laura J. Hamill: Director. Claim: alpha:claim:company:949442cd-411d-47fd-9b77-1797c485ab61:leadership_role:12. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5163f9ed312a579335fb257ccc13cd0586e4a85f31dac06879e3c5d4111a1fba.
- Mark D. Smith: Director. Claim: alpha:claim:company:949442cd-411d-47fd-9b77-1797c485ab61:leadership_role:13. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5163f9ed312a579335fb257ccc13cd0586e4a85f31dac06879e3c5d4111a1fba.
- Norbert G. Riedel: Director. Claim: alpha:claim:company:949442cd-411d-47fd-9b77-1797c485ab61:leadership_role:14. Valid from: 2013-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5163f9ed312a579335fb257ccc13cd0586e4a85f31dac06879e3c5d4111a1fba.
- Patrick G. Enright: Director. Claim: alpha:claim:company:949442cd-411d-47fd-9b77-1797c485ab61:leadership_role:15. Valid from: 2009-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5163f9ed312a579335fb257ccc13cd0586e4a85f31dac06879e3c5d4111a1fba.
- Patrick Kennedy: Director. Claim: alpha:claim:company:949442cd-411d-47fd-9b77-1797c485ab61:leadership_role:16. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5163f9ed312a579335fb257ccc13cd0586e4a85f31dac06879e3c5d4111a1fba.
- Rick E Winningham: Director. Claim: alpha:claim:company:949442cd-411d-47fd-9b77-1797c485ab61:leadership_role:17. Valid from: 2010-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5163f9ed312a579335fb257ccc13cd0586e4a85f31dac06879e3c5d4111a1fba.
- Seamus Mulligan: Director. Claim: alpha:claim:company:949442cd-411d-47fd-9b77-1797c485ab61:leadership_role:18. Valid from: 2012-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:5163f9ed312a579335fb257ccc13cd0586e4a85f31dac06879e3c5d4111a1fba.
- Bruce C. Cozadd: Chief Executive Officer. Claim: alpha:claim:company:949442cd-411d-47fd-9b77-1797c485ab61:leadership_role:19. Valid from: 2025-06-06. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f1912e4df5c97a764ba30b3ee7f1065e8620b7e361093d18345175bbd126a940.
- George Christopher Eliades: Senior Vice President & Chief Transformation Officer. Claim: alpha:claim:company:949442cd-411d-47fd-9b77-1797c485ab61:leadership_role:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:402bba04a09175380a701203c35a8a678f747ca7c3ad383f3debc8d8741c83ff.
- Heidi Manna: Executive Vice President & Chief People Officer. Claim: alpha:claim:company:949442cd-411d-47fd-9b77-1797c485ab61:leadership_role:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b85ce65319ff1a2c4184143f977ceed83462862d0857ab63b0070d834e13f562.
- Jed Black: Senior Vice President of Sleep & CNS Medicine. Claim: alpha:claim:company:949442cd-411d-47fd-9b77-1797c485ab61:leadership_role:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:62be36cde7e2e9df42550da2ff463988e18deca184e63b814eaaf1c5cf17b810.
- John Miller: Senior Vice President of Corporate Strategy. Claim: alpha:claim:company:949442cd-411d-47fd-9b77-1797c485ab61:leadership_role:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:6b85b74e60110605f7f3e38d179375bc5faad6f5aa2a80a0d9480f32b36dab55.
- Mary Elizabeth Henderson: Senior Vice President of Technical Operations. Claim: alpha:claim:company:949442cd-411d-47fd-9b77-1797c485ab61:leadership_role:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b281219bc5598584fd7bf6dee2f91a6a1d3b02a3db8b5cef38912b558d3c0d01.
- Neena Patil: Executive Vice President & Chief Legal Officer. Claim: alpha:claim:company:949442cd-411d-47fd-9b77-1797c485ab61:leadership_role:25. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:166a4f76f71d591f5e5056b7f5cb2e4570cfe914fc15de976aec31d9e9837d05.
- Patricia Carr: Senior Vice President & Chief Accounting Officer. Claim: alpha:claim:company:949442cd-411d-47fd-9b77-1797c485ab61:leadership_role:26. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f8599757d15ef98899b25bd06f34c7f05ab899cbfa6043992f6506e7e0abe366.
- Philip L. Johnson: Executive Vice President & Chief Financial Officer. Claim: alpha:claim:company:949442cd-411d-47fd-9b77-1797c485ab61:leadership_role:27. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c2fdb781875d847be1fe63b14cf6e5f29588e6b3b34ed9a2783033c5e5bd3a06.
- Renee D. Gala: President, Chief Executive Officer & Director. Claim: alpha:claim:company:949442cd-411d-47fd-9b77-1797c485ab61:leadership_role:28. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:36163f8a02eaa4ec50ecffaaef7979a9cf97f8a5997a2e1598cd7314be44173d.
- Robert Iannone: Executive Vice President, Chief Medical Officer and Global Head of Research & Development. Claim: alpha:claim:company:949442cd-411d-47fd-9b77-1797c485ab61:leadership_role:29. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:54a16fdbf0c72738b9e54b94e3263f1939a68a7d6a8d8c34a2f9ca520997def5.
- Samantha Pearce: Executive Vice President & Chief Commercial Officer. Claim: alpha:claim:company:949442cd-411d-47fd-9b77-1797c485ab61:leadership_role:30. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:74d2521b0ba9e098479c5f6c2739518cb22aaaa2085c3c9f608c93b426f4a8f9.

## Roles

- PUBLISHED

## Governance

- NOT_ASSERTED

## Board committees

- PUBLISHED

## Financials

- NOT_ASSERTED

## Workforce

- NOT_ASSERTED

## Market and index context

- PUBLISHED

## Legal Name

- Jazz Pharmaceuticals plc. Claim: alpha:claim:company:949442cd-411d-47fd-9b77-1797c485ab61:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:3ee9e379122eb4d2b8b36a393ea9d0752aec91bcc83dc73847976068d9e3a53e.

## Entity Status

- Public listing published. Claim: alpha:claim:company:949442cd-411d-47fd-9b77-1797c485ab61:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:3ee9e379122eb4d2b8b36a393ea9d0752aec91bcc83dc73847976068d9e3a53e.

## Published Fact

- US. Claim: alpha:claim:company:949442cd-411d-47fd-9b77-1797c485ab61:published_fact:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:3ee9e379122eb4d2b8b36a393ea9d0752aec91bcc83dc73847976068d9e3a53e.
- Healthcare. Claim: alpha:claim:company:949442cd-411d-47fd-9b77-1797c485ab61:published_fact:6. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:3ee9e379122eb4d2b8b36a393ea9d0752aec91bcc83dc73847976068d9e3a53e.

## Security Listing

- JAZZ (NASDAQ). Claim: alpha:claim:company:949442cd-411d-47fd-9b77-1797c485ab61:security_listing:31. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:3ee9e379122eb4d2b8b36a393ea9d0752aec91bcc83dc73847976068d9e3a53e.

## Coverage states

| Field | Value |
| --- | --- |
| Identity | PUBLISHED |
| Business | PUBLISHED |
| Leadership | PUBLISHED |
| Board and committees | PUBLISHED |
| Governance | NOT_ASSERTED |
| Financials | NOT_ASSERTED |
| Workforce | NOT_ASSERTED |
| Ownership | NOT_ASSERTED |
| Ratings | NOT_PUBLISHED |
| Market and index context | PUBLISHED |

## Public sources

- alpha:projection-evidence:3ee9e379122eb4d2b8b36a393ea9d0752aec91bcc83dc73847976068d9e3a53e: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/jazz-pharmaceuticals-plc).
- alpha:projection-evidence:document:5163f9ed312a579335fb257ccc13cd0586e4a85f31dac06879e3c5d4111a1fba: [Jazz Pharmaceuticals DEF 14A 2025-06-06](https://www.sec.gov/Archives/edgar/data/1232524/000123252425000043/jazz-20250606.htm).
- alpha:projection-evidence:document:f1912e4df5c97a764ba30b3ee7f1065e8620b7e361093d18345175bbd126a940: [JAZZ DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1232524/000123252425000043/jazz-20250606.htm).
- alpha:projection-evidence:document:402bba04a09175380a701203c35a8a678f747ca7c3ad383f3debc8d8741c83ff: [Jazz Pharmaceuticals key executives](https://financialmodelingprep.com/stable/key-executives?symbol=JAZZ).
- alpha:projection-evidence:document:b85ce65319ff1a2c4184143f977ceed83462862d0857ab63b0070d834e13f562: [Jazz Pharmaceuticals key executives](https://financialmodelingprep.com/stable/key-executives?symbol=JAZZ).
- alpha:projection-evidence:document:62be36cde7e2e9df42550da2ff463988e18deca184e63b814eaaf1c5cf17b810: [Jazz Pharmaceuticals key executives](https://financialmodelingprep.com/stable/key-executives?symbol=JAZZ).
- alpha:projection-evidence:document:6b85b74e60110605f7f3e38d179375bc5faad6f5aa2a80a0d9480f32b36dab55: [Jazz Pharmaceuticals key executives](https://financialmodelingprep.com/stable/key-executives?symbol=JAZZ).
- alpha:projection-evidence:document:b281219bc5598584fd7bf6dee2f91a6a1d3b02a3db8b5cef38912b558d3c0d01: [Jazz Pharmaceuticals key executives](https://financialmodelingprep.com/stable/key-executives?symbol=JAZZ).
- alpha:projection-evidence:document:166a4f76f71d591f5e5056b7f5cb2e4570cfe914fc15de976aec31d9e9837d05: [Jazz Pharmaceuticals key executives](https://financialmodelingprep.com/stable/key-executives?symbol=JAZZ).
- alpha:projection-evidence:document:f8599757d15ef98899b25bd06f34c7f05ab899cbfa6043992f6506e7e0abe366: [Jazz Pharmaceuticals key executives](https://financialmodelingprep.com/stable/key-executives?symbol=JAZZ).
- alpha:projection-evidence:document:c2fdb781875d847be1fe63b14cf6e5f29588e6b3b34ed9a2783033c5e5bd3a06: [Jazz Pharmaceuticals key executives](https://financialmodelingprep.com/stable/key-executives?symbol=JAZZ).
- alpha:projection-evidence:document:36163f8a02eaa4ec50ecffaaef7979a9cf97f8a5997a2e1598cd7314be44173d: [Jazz Pharmaceuticals key executives](https://financialmodelingprep.com/stable/key-executives?symbol=JAZZ).
- alpha:projection-evidence:document:54a16fdbf0c72738b9e54b94e3263f1939a68a7d6a8d8c34a2f9ca520997def5: [Jazz Pharmaceuticals key executives](https://financialmodelingprep.com/stable/key-executives?symbol=JAZZ).
- alpha:projection-evidence:document:74d2521b0ba9e098479c5f6c2739518cb22aaaa2085c3c9f608c93b426f4a8f9: [Jazz Pharmaceuticals key executives](https://financialmodelingprep.com/stable/key-executives?symbol=JAZZ).

## Rights

| Field | Value |
| --- | --- |
| public_retrieval | allowed |
| agent_retrieval | allowed |
| redistribution | not_granted |
| model_training | not_granted |
| commercial_use | not_specified |
| relationship_pathfinding | not_granted |
| direct_contact | not_granted |

## Limitations

- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.

## Alternate representations

- [Canonical profile](https://registry.alpha.ac/companies/jazz-pharmaceuticals-plc)
- [Public Markdown](https://registry.alpha.ac/companies/jazz-pharmaceuticals-plc.md)
- [Public JSON](https://registry.alpha.ac/api/public/companies/jazz-pharmaceuticals-plc?format=record)
- [JSON-LD](https://registry.alpha.ac/api/public/companies/jazz-pharmaceuticals-plc?format=jsonld)
- MCP resource: `alpha://companies/jazz-pharmaceuticals-plc` at https://mcp.alpha.ac/mcp


## Connected governance records

Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage.

## Critical-risk oversight

Snapshot as of 2026-10-16T09:56:14.395981+00:00; recorded 2026-10-16T09:56:14.395981+00:00. Every published assignment for this snapshot is listed.
Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording.
An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.